Decode Age raises ₹14.48 crore to expand longevity products, labs and offline retail
Bengaluru-based Decode Age, which sells longevity supplements and gut-microbiome tests, will use its pre-Series A funding for new formulations, testing products, lab upgrades, research and offline expansion. It reported FY24 revenue of ₹11.9 crore, with supplements contributing about 93%.
Bengaluru-based Decode Age sells longevity supplements and gut-microbiome tests, with supplements generating about 93% of revenue. After reporting FY24 revenue of ₹11.9 crore, it raised ₹14.48 crore pre-Series A funding to expand research, lab capacity, products and offline retail.
Why this matters
No related recent Decode Age signals are provided. The funding broadens Decode Age's model from supplement-led sales into testing, lab capabilities, research and offline retail.
Omni-channel is steady, with 1,665 signals tracked in the past 90 days.
Also reported by
- YourStory · Capital — Same time